ST JUDE MED Stock Price
$46.68 
Change:
-0.16 -0.17% Volume:
207,741
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 47.22 | Todays Low: 46.565 | Open: 46.84 | Last Close: 47
52 Wk High: 47.22 | 52 Wk Low: 30.25 | Todays Pivot: 46.82 | Pre market open: 44.08
Sector: Healthcare and Pharmaceuticals
Related Healthcare and Pharmaceuticals Companies
Above is a small selection of related companies to St Jude Med which compete alongside STJ within the Healthcare and Pharmaceuticals sector.
Online News For St Jude Med
|
St Jude Medical receives EU approval for vessel reconstruction system - Zenopa - Zenopa
Mon, 20 May 2013 15:52Frank Callaghan, president of the St Jude Medical cardiovascular and ablation technologies division, said: "The advancements in the Ilumien Optis system reflect the commitment by St Jude Medical to provide innovative products that reduce healthcare ...
|
|
St. Jude Medical Receives "Neutral" Rating from Goldman Sachs (STJ) - Mideast Time
Mon, 20 May 2013 14:58Shares of St. Jude Medical (NYSE: STJ) traded down 0.34% during mid-day trading on Monday, hitting $46.84. St. Jude Medical has a 52 week low of $30.25 and a 52 week high of $47.16. The stock's 50-day moving average is currently $42.2. The company ...
|
|
St. Jude Medical wins EU green light for Ilumien Optis - Mass Device
Thu, 16 May 2013 16:00St. Jude Medical (NYSE:STJ) today announced CE Mark approval of its Ilumien Optis PCI optimization system, designed to help physicians assess and treat patients with coronary artery disease. Ilumien Optis will launch in Europe next week during EuroPCR, ...
|
|
St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal ... - MarketWatch (press release)
Tue, 14 May 2013 12:01ST. PAUL, Minn., May 14, 2013 (BUSINESS WIRE) -- St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced enrollment of the first patient in the EnligHTN III trial. This study will evaluate the safety and performance of the ...
|
|
St. Jude Medical gets CE Mark approval for next-generation Ellipse and SJM ... - pharmabiz.com
Sat, 11 May 2013 09:40St. Jude Medical, Inc., a global medical device company, has received CE Mark approval for its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
|
|
St. Jude Medical kicks off renal denervation device study - Mass Device
Tue, 14 May 2013 20:07The 1st patient enrolled today in a St. Jude Medical (NYSE:STJ)-sponsored trial to evaluate the safety and performance of a new renal denervation system in patients with drug-resistant, uncontrolled hypertension, the company said. The EnligHTN systems ...
|
STJ Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time St Jude Med quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for STJ to choose from. Visit here to build your stock quote widget »
